Drugs
CompaniesEmployees are cheating on workplace drug tests at record rates—and legalized cannabis could be to blame
By Christiaan HetznerMay 15, 2024
By Richard EisenbergMay 14, 2024
TechGoogle DeepMind and Isomorphic Labs reveal AI able to predict large swathes of molecular biology
By Jeremy KahnMay 8, 2024
RetailDenmark’s Novo Nordisk forecasts 27% sales surge but faces price pressure amid Eli Lilly competition
By Naomi Kresge and BloombergMay 2, 2024
RetailNovo Nordisk’s market value of $570 billion is now bigger than the entire Danish economy—creating a ‘Nokia risk’ for Denmark
By Sanne Wass, Naomi Kresge and BloombergMay 1, 2024
PoliticsBiden’s DEA to reclassify marijuana in historic shift that still doesn’t decriminalize it, sources say
By Zeke Miller, Joshua Goodman, Jim Mustian, Lindsay Whitehurst and The Associated PressApril 30, 2024
PoliticsFrustrated by high drug prices, California will offer its own version of heavily discounted Narcan to stop fentanyl overdoses
By Adam Beam and The Associated PressApril 29, 2024
By Sage LazzaroApril 25, 2024
RetailAstraZeneca encounters a surge in shares as profits exceed expectations, buoyed by demand for cancer drugs
By Ashleigh Furlong and BloombergApril 25, 2024
FinanceMexico’s meth trade has become so lucrative it is exporting the drugs as far away as Hong Kong and Australia
By The Associated PressApril 23, 2024
By Lindsey LeakeApril 19, 2024
Lifestyle‘It’s a phenomenon’: How 4/20 grew organically from a group of Northern California high schoolers into marijuana’s holiday
By Gene Johnson and The Associated PressApril 19, 2024
By Emma BurleighApril 19, 2024
By Richard EisenbergApril 8, 2024
Most Popular
